Svar på skriftligt spörsmål om att införa vaccination mot RS-virus i det nationella vaccinationsprogrammet

This procedure concerns a written question about including the Respiratory Syncytial Virus (RSV) vaccine in Finland's national vaccination program. The question seeks to understand the rationale and process for such an inclusion, particularly for newborns. The response will likely detail the current recommendations and considerations by the Finnish Institute for Health and Welfare regarding RSV prevention and vaccination strategies for vulnerable infants.